Structural and functional abnormalities in first-episode drug-naïve pediatric idiopathic generalized epilepsy

Dingmei Deng1,2,3, Hui Sun4, Yuting Wang2,3

  • 1West China School of Public Health and West China Fourth Hospital, Sichuan University, No. 18, South Section 3, First Ring Road, Wuhou District, Chengdu 610041, China.

Insights

This study found structural and functional brain connectivity changes in children with new-onset idiopathic generalized epilepsy (IGE). These abnormalities, particularly within the default mode network (DMN), are key to understanding pediatric IGE.

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Epileptology

Background:

  • Idiopathic generalized epilepsy (IGE) is a common epilepsy syndrome in children.
  • Understanding the underlying pathological mechanisms of pediatric IGE is crucial for effective treatment.
  • Previous research has explored structural and functional brain alterations in epilepsy, but pediatric IGE requires specific investigation.

Purpose of the Study:

  • To investigate brain structure and functional connectivity (static and dynamic) abnormalities in untreated, first-episode pediatric IGE.
  • To identify specific brain regions and networks affected in pediatric IGE.
  • To elucidate the pathological mechanisms contributing to pediatric IGE.

Main Methods:

  • Recruited 31 children with IGE and 31 healthy controls (HC).
  • Acquired structural magnetic resonance imaging (sMRI) data and performed voxel-based morphometry (VBM) for gray matter volume (GMV) analysis.
  • Conducted static functional connectivity (sFC) and dynamic functional connectivity (dFC) analyses using abnormal GMV regions as seeds.

Main Results:

  • The IGE group showed increased GMV in the left middle cingulate cortex (MCC) and right parahippocampus (ParaHipp) compared to HC.
  • dFC and sFC analyses revealed more extensive functional connectivity changes with MCC and ParaHipp as seeds, particularly in dFC.
  • Affected brain regions were predominantly located within the default mode network (DMN).

Conclusions:

  • This study identified microstructural and functional connectivity alterations in new-onset, untreated pediatric IGE.
  • The default mode network (DMN) plays a significant role in the development of pediatric IGE.
  • No significant associations were found between neuroimaging findings and clinical outcomes in this cohort.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
362
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
190
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
403
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
359
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
183
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
303